Source: International Congress 2018 – Epidemiology of COPD : from exarcebations and comorbidities to asthma-COPD overlap syndrome (ACOS)
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
C. Bloom (London, United Kingdom), I. Douglas (London, United Kingdom), L. Smeeth (London, United Kingdom), J. Quint (London, United Kingdom). Description of the UK’s asthma and COPD inhaler use. 1176

Member's Comments

No comment yet.

Related content which might interest you: A digital inhaler uncovering patterns of SABA use in asthma and COPD Source: Virtual Congress 2020 – Digital health interventions in respiratory medicine Year: 2020 Comparing objective inhaler use among COPD and Asthma populations Source: International Congress 2018 – Respiratory epidemiology: from COPD to factors that associate with lung function and infections Year: 2018 Differences in inhaler misuse between patients with asthma and COPD. Source: International Congress 2018 – Pulmonary drug delivery: inhaler use, devices and technologies Year: 2018 The asthmatic patient and inhaler treatment devices profile in Turkey: Asthma inhaler treatment study Source: Annual Congress 2012 - Treatment of asthma, bronchiectasis and cough: inhaler use Year: 2012 Identification of asthma level of control using administrative data of short-acting beta-agonist inhalers purchase Source: International Congress 2016 – Monitoring airway diseases with clinical tools Year: 2016 Real-life evaluation of budesonide/formoterol (DuoResp Spiromax) for the management of asthma and COPD in the UK Source: International Congress 2017 – Primary care diagnosis, assessment and management of COPD Year: 2017 The effect of inhaler switching on asthma and COPD patients Source: International Congress 2018 – Respiratory epidemiology: from COPD to factors that associate with lung function and infections Year: 2018 Comparison of asthma and COPD patients' perception of appropriate metered-dose inhaler technique with a questionnaire and supervision based reference standard Source: International Congress 2014 – Clinical assessment of airway diseases Year: 2014 Utility of inhaled corticosteroids (fluticasone/formoterol) by pressurized metered-dose inhaler for the early management of acute exacerbations of asthma Source: Annual Congress 2010 - Aspects of severe asthma Year: 2010 Effect of switching from salmeterol/fluticasone dry powder inhaler to formoterol/fluticasone pressurized metered-dose inhaler in elderly asthma patients Source: International Congress 2016 – Asthma management Year: 2016 Preference of the inhaler device and assessment of the technique among the asthmatic and COPD patients Source: Annual Congress 2011 - Drug delivery and pharmacokinetics II Year: 2011 New soft mist inhaler is effective and easy to use in patients with asthma and COPD Source: Eur Respir J 2005; 26: Suppl. 49, 338s Year: 2005 Difference between asthma and COPD patients in adherence and non-adherence patterns to inhaler devices Source: International Congress 2015 – Is asthma always an easy disease to diagnose and manage? Year: 2015 Bronchodilators delivered by nebuliser versus pMDI for exacerbations of COPD - A Cochrane review Source: International Congress 2016 – COPD diagnosis and management Year: 2016 Hair analysis to detect chronic inhaler drug use in asthma or COPD patients Source: International Congress 2017 – Monitoring novel biomarkers in asthma Year: 2017 Comparing pharmacist time use for asthma and COPD patients using various types of inhaler devices Source: International Congress 2015 – Is asthma always an easy disease to diagnose and manage? Year: 2015 Medical personnel‘s ability to use pressurized metered dose inhaler (pMDI) in India Source: Annual Congress 2006 - The challenges of managing asthma in primary care Year: 2006 A novel NEXT DPI® dry powder inhaler and its use in asthmatic and COPD population Source: Annual Congress 2011 - Drug delivery and pharmacokinetics I Year: 2011 Preferences for current inhaler devices in patients with asthma Source: International Congress 2018 – Asthma and drugs Year: 2018